M&A Lawyers Line Up for Major Pharma Deals

Valeant launched a $45.7 billion hostile takeover bid for Botox-maker Allergan, while Novartis announced a series of transactions with GlaxoSmithKline and Eli Lilly.

Special Reports and Features

Surveys and Rankings

read more

Columnists and Blogs

read more

The Magazine

Cover Story: Dealmakers of the Year 2014

The American Lawyer
A dozen attorneys who distinguished themselves with their work on the year's most notable transactions.
read more

The Churn

read more

Lawyers in the News

read more

Editor's Picks

read more